×
  • Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
 

Japan pharmaceutical market outlook deregulation and more efficient new drug approval process attract foreign investment - Reports Corner

by Working at Reports Corner on May 03, 2013

  • 320 views

GBI Research, the leading business intelligence provider, has released its latest research “Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract ...

GBI Research, the leading business intelligence provider, has released its latest research “Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players”. Japan’s pharmaceutical industry is the second largest in the world, worth $89 billion in 2011 or 10% of the world market.

https://www.reportscorner.com/reports/15625/Japan-Pharmaceutical-Market-Outlook---Deregulation-and-More-Efficient-New-Drug-Approval-Process-Attract-Foreign-Investment-and-Improve-the-Competitiveness-of-Japanese-Players/

Statistics

Views

Total Views
320
Views on SlideShare
320
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via SlideShare as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
Post Comment
Edit your comment

Japan pharmaceutical market outlook   deregulation and more efficient new drug approval process attract foreign investment - Reports Corner Japan pharmaceutical market outlook deregulation and more efficient new drug approval process attract foreign investment - Reports Corner Presentation Transcript